- Home
- HRZN vs DRTS Comparison
HRZN vs DRTS Comparison
Compare HRZN & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRZN
- DRTS
- Stock Information
- Founded
- HRZN 2008
- DRTS 2015
- Country
- HRZN United States
- DRTS Israel
- Employees
- HRZN N/A
- DRTS N/A
- Industry
- HRZN Finance/Investors Services
- DRTS Medical/Dental Instruments
- Sector
- HRZN Finance
- DRTS Health Care
- Exchange
- HRZN Nasdaq
- DRTS Nasdaq
- Market Cap
- HRZN 251.0M
- DRTS 300.2M
- IPO Year
- HRZN 2010
- DRTS N/A
- Fundamental
- Price
- HRZN $5.85
- DRTS $3.75
- Analyst Decision
- HRZN Hold
- DRTS Strong Buy
- Analyst Count
- HRZN 4
- DRTS 1
- Target Price
- HRZN $7.38
- DRTS $9.00
- AVG Volume (30 Days)
- HRZN 719.9K
- DRTS 56.1K
- Earning Date
- HRZN 10-28-2025
- DRTS 11-18-2025
- Dividend Yield
- HRZN 22.56%
- DRTS N/A
- EPS Growth
- HRZN N/A
- DRTS N/A
- EPS
- HRZN N/A
- DRTS N/A
- Revenue
- HRZN $97,144,000.00
- DRTS N/A
- Revenue This Year
- HRZN N/A
- DRTS N/A
- Revenue Next Year
- HRZN $9.61
- DRTS N/A
- P/E Ratio
- HRZN N/A
- DRTS N/A
- Revenue Growth
- HRZN N/A
- DRTS N/A
- 52 Week Low
- HRZN $5.71
- DRTS $2.14
- 52 Week High
- HRZN $10.55
- DRTS $4.69
- Technical
- Relative Strength Index (RSI)
- HRZN 32.27
- DRTS 44.77
- Support Level
- HRZN $5.71
- DRTS $3.75
- Resistance Level
- HRZN $6.20
- DRTS $4.25
- Average True Range (ATR)
- HRZN 0.17
- DRTS 0.29
- MACD
- HRZN 0.00
- DRTS -0.07
- Stochastic Oscillator
- HRZN 20.87
- DRTS 1.06
About HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.